China's IVD Medical splurges RMB 2.877 billion on a cross-industry acquisition

Sep 02, 2025 12:05 CST Updated 21:52

According to the September 1st report from Southern Finance Intelligence IVD Medical (01931.HK) has announced a disclosable transaction in which its wholly-owned subsidiary, FinalTouch Ltd., conditionally agrees to acquire a 20.31% stake in GoFintech Quantum Innovation Limited held by the seller for approximately HK$3.142 billion (about RMB 2.877 billion). The acquisition will be settled through the issuance of consideration shares. Upon completion of the acquisition, IVD Medical will become a major shareholder of the target company and will account for the target's financial performance as an investment in an associate. This acquisition aims to enhance capital synergies, promote the implementation of the RWA ecosystem, build an innovative collaboration network, strengthen traditional financial trust endorsements, broaden the foundation for institutional cooperation, jointly establish a new on-chain financial ecosystem, and facilitate the globalization of Chinese assets.

According to reports, GoFintech Quantum Innovation Limited (00290.HK) is a cross-border and interdisciplinary technology innovation investment platform. Based in Hong Kong, supported by the Greater Bay Area, and oriented toward the global market, the company holds licenses 1, 4, 6, and 9, as well as cross-border qualifications such as QFII, CIBM, QDIE, QFLP, and Bond Connect. It has established an integrated ecosystem across four major business segments: technology innovation, finance, art, and trade. With significant strategic deployments in cutting-edge fields such as quantum technology and digital assets, the company is advancing its strategy of using investments to drive investment banking and leveraging innovation to revitalize traditional sectors, positioning itself as a global pioneer in the application of quantum technology

On September 1, 2025, IVD Medical (01931.HK) announced the acquisition of a 20.31% stake in GoFintech Quantum (00290.HK) for HK$3.142 billion, making it the single largest shareholder. The transaction was completed through the issuance of 324.3 million new shares at HK$9.69 per

IVD Medical's wholly-owned subsidiary acquires 1.848 billion shares of GoFintech Quantum, representing 20.31% of its total equity. The former major shareholder, Liu Zhiwei, sees his stake reduced to 0.97%.

After the transaction is completed, GoFintech Quantum will be included in the financial statements of IVD Medical as an associate company. Both parties will cooperate in areas such as blockchain and quantum.

IVD Medical thereby obtained the Hong Kong 1/4/6/9 financial licenses held by GoFintech Quantum, enhancing its capability to compliantly issue RWA (Real World Asset) tokens and accelerating the tokenization process of medical equipment, intellectual property, and other assets.

The two parties plan to jointly build an on-chain financial ecosystem platform to promote the compliant tokenization of Chinese medical assets, such as innovative drug patents and equipment revenue rights for global expansion, enhancing international liquidity and financing efficiency.

GoFintech Quantum, in collaboration with others, co-established the Hong Kong Digital Asset Listed Companies Federation and partnered with companies such as North King (Jingbei) and Meinian Onehealth to expand RWA application scenarios. For instance, Meinian Onehealth has piloted the tokenization of medical equipment income.

IVD Medical can leverage the 22.5% equity stake in CSOP held by GoFintech Quantum to optimize its cross-border asset management and trading.

The two parties plan to develop a comprehensive RWA ecosystem covering asset screening, compliant issuance, and cross-border transactions, aiming to connect trillions of dollars in global real-world assets and capital, and to secure a leading position in the convergence of healthcare and financial technology.

Source: China IVD Network